Riskpilot← Back to searchSign inGet full accessX-Ray Vision AB
ABActiveOrg 5591987382Banvägen 21General medical practice activities · NACE 8621Est. 20190 employees
Revenue 2024
SEK 20K
EBITDA margin
35.0%
Equity ratio
107.7%
Financial strength
Net profit 2024
SEK 5K
0 employees
| Revenue | SEK 20K | — |
| EBITDA | SEK 7K | — |
| Net profit | SEK 5K | — |
| Total assets | SEK 65K | — |
| Equity | SEK 70K | — |
| Employees | 0 | — |
Legal name
X-Ray Vision AB
Org number
5591987382
Legal form
Aktiebolag
NACE code
8621 · General medical practice activities
Founded
14 mars 2019
Share capital
SEK 50 000
Employees
0
VAT registered
Yes
Audit selected
No
Last report
2024-12-31
Financial year
January – December
Signatory rights
Firman tecknas av styrelsen Firman tecknas var för sig av ledamöterna
Company purpose
Företaget ska bedriva rådgivning inom den medicinska sektorn, konsultverksamhet inom digitalisering, rådgivare och utbildare inom vildmarksfrågor.
Address
Banvägen 21
Email
xray.visionab@gmail.com
Risika for professionals
Risika provides regulated workflow tools for finance, procurement and compliance teams that need monitoring, alerts and an API.
| Item | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|
| Revenue | 30 | 51 | 0 | — | 20 |
| Staff expenses | — | — | — | — | — |
| EBITDA | 3 | 29 | −12 | 0 | 7 |
| Depreciation & amort. | −0 | −0 | — | — | −0 |
| EBIT | 3 | 29 | −12 | 0 | 7 |
| Net financials | — | — | −0 | — | — |
| Profit before tax | 3 | 29 | −12 | 0 | 6 |
| Tax | −1 | −6 | — | — | −1 |
| Net profit | 2 | 23 | −12 | — | 5 |
| Item | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|
| Total assets | 60 | 93 | 76 | — | 65 |
| Equity | 55 | 79 | 67 | — | 70 |
| Long-term debt | 0 | 0 | — | — | 0 |
| Short-term debt | 4 | 14 | 9 | — | 5 |
| Total debt | 4 | 14 | 9 | — | 5 |
EBITDA margin
35.0%
This company
15.8%
Market median
+122% vs market
20202024
Equity ratio
107.7%
This company
38.2%
Market median
+182% vs market
20202024
Return on equity
7.1%
This company
18.4%
Market median
-61% vs market
20202024
Net profit margin
25.0%
This company
8.1%
Market median
+209% vs market
20202024
Asset turnover
0.31×
This company
1.12×
Market median
-72% vs market
20202024
Debt / equity
-0.07×
This company
0.62×
Market median
+111% vs market
20202024
- Annual report 2024Filed via Bolagsverket / SCB · Period 2024-01-01 – 2024-12-31
- Annual report 2023Filed via Bolagsverket / SCB · Period 2023-01-01 – 2023-12-31
- Annual report 2022Filed via Bolagsverket / SCB · Period 2022-01-01 – 2022-12-31
- Annual report 2021Filed via Bolagsverket / SCB · Period 2021-01-01 – 2021-12-31
- Annual report 2020Filed via Bolagsverket / SCB · Period 2020-01-01 – 2020-12-31
| Name | Role | Member since |
|---|---|---|
| Current (1) | ||
AJ Chief Executive Officer | Chief Executive Officer | 2022 |
| Name | Role | Member since |
|---|---|---|
| Current (2) | ||
| Chairman | 2022 | |
| Deputy Board Member | 2022 | |
No shareholder data available.
Beneficial ownership (UBO) data access is restricted in Denmark as of September 2025 per the EU 6th AML Directive. Learn more.
No registered parent or subsidiaries
Board members of X-Ray Vision AB also hold positions in 0 other companies.
| Person | Role here | Other companies |
|---|---|---|
| Augustinus Joseph Michael Creusen | Chief Executive Officer | 0 companies |
| Angeliki Dimopoulou Creusen | Chairman | 0 companies |
| Maria Dimopoulou | Deputy Board Member | 0 companies |